Hereditary Predisposition to Thrombosis in Children
Introduction to Hereditary Predisposition to Thrombosis in Children
Hereditary thrombophilia refers to genetic conditions that increase the risk of thrombosis (blood clot formation) in children. While thrombotic events are less common in children compared to adults, they can have significant morbidity and mortality. Understanding the genetic factors contributing to thrombosis is crucial for proper diagnosis, management, and prevention of thrombotic events in pediatric patients.
Hereditary Predisposition to Thrombosis in Children
- What is hereditary thrombophilia?
Hereditary thrombophilia refers to inherited conditions that increase the risk of abnormal blood clot formation - Which genetic mutation is most commonly associated with hereditary thrombophilia in children?
Factor V Leiden mutation is the most common inherited thrombophilia - What is the inheritance pattern of Factor V Leiden mutation?
Autosomal dominant inheritance with variable penetrance - How does prothrombin G20210A mutation increase thrombosis risk?
It leads to increased prothrombin levels, enhancing thrombin generation and clot formation - What is the significance of homozygous vs. heterozygous mutations in hereditary thrombophilia?
Homozygous mutations generally confer a higher thrombosis risk compared to heterozygous mutations - Which natural anticoagulant deficiencies are associated with hereditary thrombophilia?
Deficiencies of antithrombin, protein C, and protein S - How does antithrombin deficiency affect thrombosis risk in children?
Antithrombin deficiency is associated with a high risk of both venous and arterial thrombosis, even in childhood - What is the role of protein C in normal hemostasis?
Protein C is a natural anticoagulant that inactivates factors Va and VIIIa - How does protein S deficiency manifest in children?
Protein S deficiency can cause venous thromboembolism, with increased risk during adolescence and in the presence of additional risk factors - What is the significance of elevated factor VIII levels in pediatric thrombophilia?
Persistently elevated factor VIII levels are an independent risk factor for thrombosis in children - How does hyperhomocysteinemia contribute to thrombosis risk?
Elevated homocysteine levels can damage endothelium and activate coagulation, increasing thrombosis risk - What is the role of MTHFR mutations in pediatric thrombophilia?
MTHFR mutations alone do not significantly increase thrombosis risk but may contribute in combination with other risk factors - How does the presence of multiple thrombophilic defects affect thrombosis risk in children?
The presence of multiple thrombophilic defects has a synergistic effect, significantly increasing thrombosis risk - What is the most common site of thrombosis in children with hereditary thrombophilia?
Deep veins of the lower extremities are the most common site, followed by cerebral venous sinuses - How does oral contraceptive use affect thrombosis risk in adolescents with hereditary thrombophilia?
Oral contraceptives significantly increase thrombosis risk, especially in those with Factor V Leiden or prothrombin mutations - What is the role of genetic testing in asymptomatic children with a family history of thrombophilia?
Routine genetic testing is controversial in asymptomatic children and should be considered on a case-by-case basis - How does obesity interact with hereditary thrombophilia in children?
Obesity compounds thrombosis risk in children with hereditary thrombophilia through various mechanisms, including inflammation and stasis - What is the significance of antiphospholipid antibodies in children with hereditary thrombophilia?
The presence of antiphospholipid antibodies can further increase thrombosis risk in children with hereditary thrombophilia - How does hereditary thrombophilia affect the risk of catheter-related thrombosis in children?
Hereditary thrombophilia increases the risk of catheter-related thrombosis, particularly with central venous catheters - What is the role of thromboelastography in assessing children with hereditary thrombophilia?
Thromboelastography can provide a global assessment of hemostasis but is not specific for diagnosing hereditary thrombophilia - How does hereditary thrombophilia affect the risk of stroke in children?
Certain thrombophilias, particularly antithrombin deficiency and protein C deficiency, increase the risk of arterial ischemic stroke in children - What is the significance of elevated lipoprotein(a) levels in pediatric thrombophilia?
Elevated lipoprotein(a) is an independent risk factor for arterial thrombosis in children - How does the presence of hereditary thrombophilia affect the management of Legg-Calvé-Perthes disease in children?
Hereditary thrombophilia may increase the risk and severity of Legg-Calvé-Perthes disease, potentially influencing treatment decisions - What is the role of D-dimer testing in children with hereditary thrombophilia?
D-dimer testing can be useful in acute thrombosis evaluation but is not diagnostic of hereditary thrombophilia - How does hereditary thrombophilia affect the risk of pregnancy complications in adolescents?
Hereditary thrombophilia increases the risk of pregnancy-related complications such as recurrent miscarriage and placental abruption - What is the significance of a positive family history in assessing thrombosis risk in children?
A positive family history of thrombosis, especially in first-degree relatives, significantly increases a child's thrombosis risk - How does hereditary thrombophilia affect the choice of contraception in adolescents?
Non-hormonal or progestin-only contraceptives are generally preferred in adolescents with hereditary thrombophilia - What is the role of thromboprophylaxis in asymptomatic children with hereditary thrombophilia?
Routine thromboprophylaxis is not recommended for asymptomatic children but may be considered in high-risk situations - How does the presence of hereditary thrombophilia affect the management of pediatric inflammatory bowel disease?
It may influence decisions regarding thromboprophylaxis during disease flares and hospitalization - What is the significance of JAK2 mutations in pediatric thrombophilia?
JAK2 mutations are associated with myeloproliferative neoplasms and can increase thrombosis risk in affected children - How does hereditary thrombophilia affect the risk of cerebral sinovenous thrombosis in neonates?
Certain thrombophilias, particularly Factor V Leiden, increase the risk of cerebral sinovenous thrombosis in neonates - What is the role of global coagulation assays in assessing children with hereditary thrombophilia?
Global assays like thrombin generation tests can provide insight into overall thrombotic potential but are not routinely used - How does the presence of hereditary thrombophilia affect the management of pediatric nephrotic syndrome?
It may influence decisions regarding thromboprophylaxis, especially during periods of severe hypoalbuminemia - What is the significance of protein Z deficiency in pediatric thrombophilia?
Protein Z deficiency may contribute to thrombosis risk, particularly in combination with other thrombophilic factors - How does hereditary thrombophilia affect the risk of portal vein thrombosis in children?
Hereditary thrombophilia increases the risk of portal vein thrombosis, particularly in children with underlying liver disease - What is the role of thrombophilia testing in children with arterial ischemic stroke?
Thrombophilia testing is often performed in children with arterial ischemic stroke, but its impact on management remains controversial - How does the presence of hereditary thrombophilia affect the management of sickle cell disease in children?
It may increase the risk of vaso-occlusive events and influence decisions regarding chronic transfusion therapy - What is the significance of plasminogen activator inhibitor-1 (PAI-1) polymorphisms in pediatric thrombophilia?
PAI-1 polymorphisms may contribute to thrombosis risk by impairing fibrinolysis, particularly in combination with other risk factors